PBX1 was identified as new markers for minimal residual disease detection in acute lymphoblastic leukaemia. PBX1 was differentially expressed in up to 81.4% of acute lymphoblastic leukaemia cases. This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.